About Us:
Structure Therapeutics develops life‐changing medicines for patients using advanced structure‐based and computational drug discovery technology. The company’s platform combines the latest advancements in visualization of molecular interactions, computational chemistry, and data integration to design orally available, superior small molecule medicines that overcome current limitations of biologic and peptide drugs. We are advancing a clinical‐stage pipeline of differentiated treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic, and pulmonary conditions.
Structure Therapeutics is led by an experienced group of international drug innovators and financed by top-tier global life sciences investors. The company completed an initial public offering (IPO) in February 2023. With offices in California and Shanghai, Structure Therapeutics has the benefit of being at the center of life science innovation in both the US and China and capitalizing on the strengths of each geographic location.
Position Summary:
Reporting to the Senior Director of Chemistry, this position will be responsible for leading SAR studies of one or more GKAR chemical series to deliver milestones working closely with biology/Sbio/CADD/IP/CRO.
Job Responsibilities:
Qualifications:
Job details are sourced from the employer's original posting.
Open job postingAbout the company
Structuretx is a clinical research organization (CRO) that provides services for clinical trial management. They focus on drug development and adhere to ICH guidelines/GCP.